Viking Therapeutics
VKTX
#2272
Rank
NZ$11.39 B
Marketcap
$102.23
Share price
-3.76%
Change (1 day)
506.79%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$44.6 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are NZ$44.6 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$31.73 M-13.17%
2022-12-31NZ$36.55 M184.42%
2021-12-31NZ$12.85 M-23.73%
2020-12-31NZ$16.85 M59%
2019-12-31NZ$10.59 M55.82%
2018-12-31NZ$6.8 M-44.21%
2017-12-31NZ$12.18 M30.04%
2016-12-31NZ$9.37 M-4.45%
2015-12-31NZ$9.8 M-69.46%
2014-12-31NZ$32.12 M6025.4%
2013-12-31NZ$0.52 M309.3%
2012-12-31NZ$0.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$2.00 B 4,385.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.47 B 3,211.51%๐Ÿ‡บ๐Ÿ‡ธ USA